Goebeler M, Kilian K, Gillitzer R, Kunz M, Yoshimura T, Bröcker E B, Rapp U R, Ludwig S
Klinik und Poliklinik für Haut- und Geschlechtskrankheiten and Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), Universität Würzburg, Würzburg, Germany.
Blood. 1999 Feb 1;93(3):857-65.
Monocyte chemoattractant protein-1 (MCP-1), a member of the C-C subfamily of chemokines, is important for the local recruitment of leukocytes to sites of inflammatory challenge. Here, we investigated endothelial signaling pathways involving members of the mitogen-activated protein (MAP) kinase superfamily and studied their role for MCP-1 expression in endothelium. We show that tumor necrosis factor-alpha (TNF-alpha), a potent inflammatory activator of endothelium, leads to activation of MAP kinases ERK, p38, and JNK in human umbilical vein endothelial cells (HUVEC). Contribution of MAP kinase pathways to TNF-alpha-induced synthesis of endothelial MCP-1 was then studied by pharmacologic inhibition and transient expression of dominant negative or constitutively active kinase mutants using flow cytometry, Northern blot, and luciferase reporter gene assays. Inhibition of Raf/MEK/ERK or SEK/JNK pathways had no significant effect on MCP-1 levels, whereas blocking the MKK6/p38 pathway by p38 inhibitors SB203580 or SB202190 or by a dominant negative mutant of MKK6, the upstream activator of p38, strongly inhibited TNF-alpha-induced expression of MCP-1. Consistent with that finding, expression of wild-type or constitutively active MKK6 significantly enhanced the effect of limiting TNF-alpha concentrations on MCP-1 synthesis. These data suggest a crucial role for the MKK6/p38 stress kinase cascade in TNF-alpha-mediated endothelial MCP-1 expression.
单核细胞趋化蛋白-1(MCP-1)是趋化因子C-C亚家族的成员,对于白细胞向炎症刺激部位的局部募集很重要。在此,我们研究了涉及丝裂原活化蛋白(MAP)激酶超家族成员的内皮信号通路,并探讨了它们在内皮细胞中对MCP-1表达的作用。我们发现,肿瘤坏死因子-α(TNF-α)作为内皮细胞的一种强效炎症激活剂,可导致人脐静脉内皮细胞(HUVEC)中的MAP激酶ERK、p38和JNK活化。然后,我们通过药理学抑制以及使用流式细胞术、Northern印迹和荧光素酶报告基因检测法瞬时表达显性阴性或组成型活性激酶突变体,研究了MAP激酶通路对TNF-α诱导的内皮MCP-1合成的贡献。抑制Raf/MEK/ERK或SEK/JNK通路对MCP-1水平没有显著影响,而用p38抑制剂SB203580或SB202190或用p38的上游激活剂MKK6的显性阴性突变体阻断MKK6/p38通路,则强烈抑制TNF-α诱导的MCP-1表达。与该发现一致,野生型或组成型活性MKK6的表达显著增强了低浓度TNF-α对MCP-1合成的影响。这些数据表明,MKK6/p38应激激酶级联在TNF-α介导的内皮MCP-1表达中起关键作用。